Dabidol is the trade name and generic name of Dupliyuzumab Injection, which is generally not a lifelong medication. Duprizolizumab Injection is generally used for the treatment of moderate to severe atopic dermatitis in adults, but also has the effect of treating eczema, reducing fungal infections on the surface of the skin, improving the severity of the disease, and relieving the itching and pain of the skin caused by the disease. The drug generally does not require lifelong use, the specific time of use and the dosage of the drug should be adjusted under the guidance of a specialist, to avoid unauthorized discontinuation or increase the dosage of the drug, causing damage to the body. Symptoms such as allergy, infection and eye pain may occur in some people after use. It is contraindicated for those who have hypersensitivity to the active ingredients of the product or any other excipients. Atopic dermatitis should be under the advice of a doctor, choose the appropriate medication for treatment, pay attention to skin cleaning in daily life, avoid scratching the skin, try to avoid contact with allergens, eat more fresh fruits and vegetables, and strengthen exercise.